Latest Conference Articles

Understanding Long-Term Pediatric SARS-CoV-2 Antibodies

Understanding Long-Term Pediatric SARS-CoV-2 Antibodies

October 2nd 2021, 1:00pm

ID Week

A new study from IDWeek showed most observed children previously infected with SARS-CoV-2 retained antibodies over 6 months.

Long-Acting Injectable PrEP for HIV Risk

Long-Acting Injectable PrEP for HIV Risk

October 2nd 2021, 11:00am

ID Week

An expert reviews cabotegravir, islatravir, lenacapavir, and what other promising agents that could redefine long-term HIV prevention.

Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases

Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases

October 1st 2021, 8:17pm

ID Week

The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.

Ferring's Investigational Therapy RBX2660 Demonstrates Another Potential Offering for C Diff Treatment

Ferring's Investigational Therapy RBX2660 Demonstrates Another Potential Offering for C Diff Treatment

October 1st 2021, 7:24pm

ID Week

A clinician provides an overview of the data on the microbiota-based live biotherapeutic, RBX2660, which in phase 3 studies has shown safety and reduction in recurrent C difficile infection (rCDI).

Risk Factors Associated with Readmission after COVID-19 Hospitalization

Risk Factors Associated with Readmission after COVID-19 Hospitalization

October 1st 2021, 6:34pm

ID Week

After an initial hospitalization for COVID-19, some patients may have specific risk factors that increase their likelihood of readmittance.

Determining Weight Gain on ART Therapy

Determining Weight Gain on ART Therapy

October 1st 2021, 6:23pm

ID Week

Investigators wanted to understand this phenomenon with a group of antiretroviral (ART) naïve people with HIV (PWH).

Antimicrobial Resistance and Changes to the Gut Microbiome after International Travel

Antimicrobial Resistance and Changes to the Gut Microbiome after International Travel

October 1st 2021, 5:01pm

ID Week

Massachusetts General Hospital investigated how international travel contributes to the contraction and carriage of antimicrobial resistance (AMR).

People Living With HIV Experience a Diminished Immune Response to COVID-19 mRNA Vaccines

People Living With HIV Experience a Diminished Immune Response to COVID-19 mRNA Vaccines

October 1st 2021, 3:15pm

ID Week

Major predictors of response were CD4+ count, suppressed viral load, and whether the participant received the Moderna or Pfizer mRNA vaccine.

Delta Variant Causes Unprecedented COVID-19 Disease in Children

Delta Variant Causes Unprecedented COVID-19 Disease in Children

October 1st 2021, 3:00pm

ID Week

The Arkansas Health Department’s research showed that, as with the rest of the population, Delta is severely infectious for children.

Assessing Breakthrough Infections Associated with the AZD1222 Vaccine

Assessing Breakthrough Infections Associated with the AZD1222 Vaccine

October 1st 2021, 2:00pm

ID Week

Investigators examined asymptomatic infection and the duration of viral shedding in symptomatic breakthrough infections in a phase 3 study with the AZD1222 COVID-19 vaccine.